Succinylcholine
Mechanism: ACh receptor agonist → sustained depolarization → flaccid paralysis.
Calculate dose for your patient
Enter weight (kg or lb). Always verify before administration.
Weight is saved on this device for the next calculator you open.
Full dose calculatorDosing
Indications
- Rapid sequence intubation
- Laryngospasm
- Brief paralysis
Contraindications
- History or family hx of malignant hyperthermia
- Hyperkalemia (K+ rises ~0.5 mEq/L; up to 5–10 mEq/L in susceptible)
- Major burns >24–48 h old
- Denervation injury / prolonged immobility
- Muscular dystrophy (Duchenne)
- Pseudocholinesterase deficiency
Side Effects
- Fasciculations & myalgia
- Hyperkalemia
- Bradycardia (esp. peds, repeat dosing)
- Increased intragastric / IOP / ICP
- MH trigger
Clinical Pearls
References & Further Reading
- 1Textbook
Flood P, Rathmell JP, Shafer S. Stoelting's Pharmacology and Physiology in Anesthetic Practice. 5th ed. Philadelphia: Wolters Kluwer; 2015.
- 2Textbook
Gropper MA, Miller RD, Cohen NH, et al., eds. Miller's Anesthesia. 9th ed. Philadelphia: Elsevier; 2020.
- 3Textbook
Barash PG, Cullen BF, Stoelting RK, Cahalan MK, Stock MC, Ortega R, Sharar SR, Holt NF. Clinical Anesthesia. 8th ed. Philadelphia: Wolters Kluwer; 2017.
- 4SocietyOpen source
Malignant Hyperthermia Association of the United States (MHAUS). Recognition and Treatment of MH. Hotline 1-800-MH-HYPER. mhaus.org.
- 5Textbook
Adriano A, Morris R, eds. 2021 CA-1 Tutorial Textbook (15th Ed.). Stanford University Medical Center, Department of Anesthesiology.
Citations are provided to direct further study. Always check the most current edition of guidelines and society recommendations — the information in this chapter is a teaching summary, not primary source material.